TORRENT PHARMACEUTICALS
🇮🇳India
- Country
- 🇮🇳India
- Ownership
- -
- Established
- 1959-01-01
- Employees
- -
- Market Cap
- $13.7B
Efficacy and Safety of TRC041266 in Patients With Heart Failure, LVEF ≥40%, Diastolic Dysfunction and Type 2 Diabetes Mellitus
- First Posted Date
- 2020-08-11
- Last Posted Date
- 2022-12-27
- Lead Sponsor
- Torrent Pharmaceuticals Limited
- Registration Number
- NCT04507347
Study Comparing Test to Aczone 7.5% and Both to a Placebo Control in the Treatment of Acne Vulgaris
- First Posted Date
- 2019-07-11
- Last Posted Date
- 2020-04-02
- Lead Sponsor
- Torrent Pharmaceuticals Limited
- Target Recruit Count
- 1150
- Registration Number
- NCT04015375
- Locations
- 🇧🇿
Dermatology & Skin Surgery Centre/ FXM Research International, Belize City, Belize
🇧🇿Dr. Moguel's Clinic/ FXM Research International, Belize City, Belize
🇺🇸Unison Center for Clinical Trials, Sherman Oaks, California, United States
Bioequivalence Study of Torrent Pharmaceuticals's Ltd's Nebivolol 20 mg Tablet
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2018-05-07
- Last Posted Date
- 2018-05-07
- Lead Sponsor
- Torrent Pharmaceuticals Limited
- Target Recruit Count
- 22
- Registration Number
- NCT03517020
Bioequivalence Study of Torrent Pharmaceuticals Ltd's Nebivolol 20 mg Tablet
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2018-05-07
- Last Posted Date
- 2018-05-07
- Lead Sponsor
- Torrent Pharmaceuticals Limited
- Target Recruit Count
- 30
- Registration Number
- NCT03517033
Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Olmesartan Medoxomil Tablets Under Fed Conditions
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2017-10-24
- Last Posted Date
- 2017-10-24
- Lead Sponsor
- Torrent Pharmaceuticals Limited
- Target Recruit Count
- 34
- Registration Number
- NCT03319706
Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Olmesartan Medoxomil Tablet Under Fasting Conditions
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2017-10-23
- Last Posted Date
- 2017-10-23
- Lead Sponsor
- Torrent Pharmaceuticals Limited
- Target Recruit Count
- 34
- Registration Number
- NCT03318354
Safety and Efficacy Study of TRC150094 to Improve the CV Risk in Subjects With Diabetes, Dyslipidemia and Hypertension
- First Posted Date
- 2017-08-18
- Last Posted Date
- 2020-07-17
- Lead Sponsor
- Torrent Pharmaceuticals Limited
- Target Recruit Count
- 1250
- Registration Number
- NCT03254446
- Locations
- 🇮🇳
Ashirwad Hospital & Research Centre, Ulhasnagar, Maharashtra, India
🇵🇭De La Salle Heath Sciences Institute, Dasmariñas, Cavite, Philippines
🇮🇳Diabetes ,Thyroid and Endocrine Centre, Jaipur, Rajasthan, India
Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Fluoxetine Tablets Under Fed Conditions
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2016-11-16
- Last Posted Date
- 2016-11-16
- Lead Sponsor
- Torrent Pharmaceuticals Limited
- Target Recruit Count
- 26
- Registration Number
- NCT02965274
Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Fluoxetine Tablet Under Fasting Conditions
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2016-11-16
- Last Posted Date
- 2016-11-16
- Lead Sponsor
- Torrent Pharmaceuticals Limited
- Target Recruit Count
- 26
- Registration Number
- NCT02965261
BE Study of Torrent's Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide Tab - Fed Conditions
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2016-11-11
- Last Posted Date
- 2016-11-11
- Lead Sponsor
- Torrent Pharmaceuticals Limited
- Target Recruit Count
- 34
- Registration Number
- NCT02962258
© Copyright 2024. All Rights Reserved by MedPath